1Cancer Metastasis Laboratory, University College London Cancer Institute, London, United Kingdom. 2Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, United Kingdom.
AACR Journals Blood Cancer Discovery Cancer Discovery Cancer Epidemiology, Biomarkers & Prevention Cancer Immunology Research Cancer Prevention Research Cancer Research Cancer Research Communications ...
AACR Journals Blood Cancer Discovery Cancer Discovery Cancer Epidemiology, Biomarkers & Prevention Cancer Immunology Research Cancer Prevention Research Cancer Research Cancer Research Communications ...
1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 ...
1Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, Florida. 2Immunology, Genome Regulation and Cell Signaling Program, The Wistar Institute, Philadelphia ...
Surveillance and Health Equity Science, American Cancer Society, Atlanta, Georgia. *Corresponding Author: Priti Bandi, Risk Factors and Screening Research, Surveillance and Health Equity Science, ...
1Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany. 2Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer ...
Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain. Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), ...
1Department of Internal Medicine, Seoul National University Hospital, Seoul, the Republic of South Korea.
1Centre for Cell Factories and Biopolymers (CCFB), Griffith Institute for Drug Discovery, Griffith University (Nathan Campus), Brisbane, Queensland, Australia. Search for other works by this author on ...
1Department of Pediatrics, Stanford University, Stanford, California. 2Department of Genetics, Stanford University, Stanford, California.
Divarasib plus cetuximab is well tolerated in patients with KRAS G12C-positive colorectal cancer.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈